Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Portage Biotech Inc. (PRTG : NSDQ)
 
 • Company Description   
Portage Biotech Inc. is a clinical stage immuno-oncology company focused on overcoming immune resistance. The company source, nurture and develop therapies for a variety of cancers. Its drug development pipeline portfolio encompasses products or technologies with established scientific rationales, including intratumorals, nanoparticles, liposomes, aptamers, cell penetrating peptides, and virus-like particles. Portage Biotech Inc. is based in Tortola, British Virgin Islands.

Number of Employees:

 
 • Price / Volume Information   
Yesterday's Closing Price: $8.14 Daily Weekly Monthly
20 Day Moving Average: 40,892 shares
Shares Outstanding: 13.35 (millions)
Market Capitalization: $108.63 (millions)
Beta: 0.46
52 Week High: $44.98
52 Week Low: $4.62
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 38.32% 55.77%
12 Week -1.33% 8.46%
Year To Date -24.14% -24.62%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
Craigmuir Chambers Road Town
-
Tortola,D8 VG1110
-
ph: 416-929-1806
fax: -
None http://www.portagebiotech.com
 
 • General Corporate Information   
Officers
Ian Walters - Chief Executive Officer
Gregory Bailey - Chairman
Allan Shaw - Chief Financial Officer
Kam Shah - Director
Steven Mintz - Director

Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: G7185A128
SIC: 1311
Fiscal Year
Fiscal Year End: March
Last Reported Quarter: 12/01/21
Next Expected EPS Date: 07/27/22
Share - Related Items
Shares Outstanding: 13.35
Most Recent Split Date: (:1)
Beta: 0.46
Market Capitalization: $108.63 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.33 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-1.51 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 07/27/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 0.63
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -18.18%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
03/31/22 - -
12/31/21 - -13.23
09/30/21 - -16.07
ROA
03/31/22 - -
12/31/21 - -11.46
09/30/21 - -13.86
Current Ratio
03/31/22 - -
12/31/21 - 41.31
09/30/21 - 21.31
Quick Ratio
03/31/22 - -
12/31/21 - 41.31
09/30/21 - 21.31
Operating Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Net Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Pre-Tax Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Book Value
03/31/22 - -
12/31/21 - 12.87
09/30/21 - 13.02
Inventory Turnover
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Equity
03/31/22 - -
12/31/21 - 0.00
09/30/21 - 0.00
Debt-to-Capital
03/31/22 - -
12/31/21 - 0.00
09/30/21 - 0.00
 

Powered by Zacks Investment Research ©